Julio Lorenzi to Humans
This is a "connection" page, showing publications Julio Lorenzi has written about Humans.
Connection Strength
0.029
-
Nanobodies from camelid mice and llamas neutralize SARS-CoV-2 variants. Nature. 2021 07; 595(7866):278-282.
Score: 0.002
-
Bispecific IgG neutralizes SARS-CoV-2 variants and prevents escape in mice. Nature. 2021 05; 593(7859):424-428.
Score: 0.002
-
Antibody potency, effector function, and combinations in protection and therapy for SARS-CoV-2 infection in vivo. J Exp Med. 2021 03 01; 218(3).
Score: 0.002
-
Longitudinal Serological Analysis and Neutralizing Antibody Levels in Coronavirus Disease 2019 Convalescent Patients. J Infect Dis. 2021 02 13; 223(3):389-398.
Score: 0.002
-
Evolution of antibody immunity to SARS-CoV-2. Nature. 2021 03; 591(7851):639-644.
Score: 0.002
-
COVID-19 antibody development fueled by HIV-1 broadly neutralizing antibody research. Curr Opin HIV AIDS. 2021 01; 16(1):25-35.
Score: 0.002
-
Enhanced SARS-CoV-2 neutralization by dimeric IgA. Sci Transl Med. 2021 01 20; 13(577).
Score: 0.002
-
Measuring SARS-CoV-2 neutralizing antibody activity using pseudotyped and chimeric viruses. J Exp Med. 2020 11 02; 217(11).
Score: 0.002
-
Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants. Elife. 2020 10 28; 9.
Score: 0.002
-
Convergent antibody responses to SARS-CoV-2 in convalescent individuals. Nature. 2020 08; 584(7821):437-442.
Score: 0.002
-
Relationship between intact HIV-1 proviruses in circulating CD4+ T cells and rebound viruses emerging during treatment interruption. Proc Natl Acad Sci U S A. 2018 11 27; 115(48):E11341-E11348.
Score: 0.002
-
Combination therapy with anti-HIV-1 antibodies maintains viral suppression. Nature. 2018 09; 561(7724):479-484.
Score: 0.002
-
A non-functional galanin receptor-2 in a multiple sclerosis patient. Pharmacogenomics J. 2019 02; 19(1):72-82.
Score: 0.002
-
Relationship between latent and rebound viruses in a clinical trial of anti-HIV-1 antibody 3BNC117. J Exp Med. 2018 09 03; 215(9):2311-2324.
Score: 0.002
-
Neutralizing Activity of Broadly Neutralizing Anti-HIV-1 Antibodies against Clade B Clinical Isolates Produced in Peripheral Blood Mononuclear Cells. J Virol. 2018 03 01; 92(5).
Score: 0.002
-
Exome sequencing of multiple-sclerosis patients and their unaffected first-degree relatives. BMC Res Notes. 2017 Dec 12; 10(1):735.
Score: 0.001
-
Non-neutralizing Antibodies Alter the Course of HIV-1 Infection In Vivo. Cell. 2017 Aug 10; 170(4):637-648.e10.
Score: 0.001